Physicians dealing with sexual dysfunction (SD) must consider the psychological and behavioral aspects of their patient's diagnosis and management, as well as organic causes and risk factors. Integrating sex therapy and other psychological techniques into their office practice will improve effectiveness in treating SD. This presentation provides information about the psychological forces of patient and partner resistance, which impact patient compliance and sex lives beyond organic illness and mere performance anxiety. Four key areas are reviewed: (1) 'Sex coaching for physicians' uses the 'Cornell Model' for conceptualizing and treating SD. A 5-min 'sex status,' manages 'time crunch' by rapidly identifying common causes of sexual dysfunction (insufficient stimulation, depression, etc). (2) Augmenting pharmacotherapy with sex therapy when treating erectile dysfunction (ED) specifically, or SD generally is stressed. Sex therapy is useful as a monotherapy or an adjunctive treatment and is often the 'combination therapy' of choice when treating SD. The following therapeutic integrations are highlighted: modifying patient's initial expectations; sexual pharmaceuticals use as a therapeutic probe; 'follow-up' to manage noncompliance and improve outcome; relapse prevention. (3) Issues specific to the role of the partner of the ED patient are described. The physician must appreciate the role of couple's issues in causing and/or exacerbating the ED and the impact of the ED on the patient/partner relationship. Successful treatment requires a supportive available sexual partner, yet partner cooperation may be independent of partner attendance during the office visit. Preliminary data from a survey of SMSNA members practice patterns, regarding partner issues, is presented and discussed. The importance of evoking partner support and cooperation independent of actual attendance during office visits is emphasized. (4) Finally, the need for more patient and partner educational materials to assist the physician in overcoming a patient/partner's emotional barriers to sexual success in a time efficient manner are discussed.
Introduction
Physicians dealing with sexual dysfunction (SD) must consider the psychological and behavioral aspects of their patient's diagnosis and management, as well as organic causes and risk factors. Integrating sex therapy and other psychological techniques into their office practice will improve effectiveness in treating SD. This presentation provided information about the psychological forces of patient and partner resistance, which impact patient compliance and sex lives beyond organic illness and mere performance anxiety. There were four key areas of focus:
A. 'Sex coaching for physicians' used the 'Cornell Model' for conceptualizing and treating SD. A 5-min 'sex status,' managed 'time crunch' by rapidly identifying common causes of sexual dysfunction (insufficient stimulation, depression, etc). 1, 2 B. Augmenting pharmacotherapy with sex therapy when treating erectile dysfunction (ED) specifically, or SD generally was stressed. Sex therapy is useful as a monotherapy or an adjunctive treatment and is often the 'combination therapy' of choice when treating SD. The following therapeutic integrations were highlighted: modifying patient's initial expectations; using sexual pharmaceuticals as a therapeutic probe; using 'follow-up' to manage noncompliance and improve outcome; relapse prevention strategies.
or exacerbating the ED and the impact of the ED on the patient/partner relationship. Successful treatment required a supportive available sexual partner, yet partner cooperation may be independent of partner attendance during the office visit. Preliminary data from a survey of SMSNA members practice patterns, regarding partner issues, was presented and discussed. The importance of evoking partner support and cooperation independent of actual attendance during office visits was emphasized.
D. Finally, the need for more patient and partner educational materials to assist the physician, in overcoming a patient/partner's emotional barriers to sexual success in a time efficient manner was discussed.
Sex coaching for physicians
Incorporating sex therapy and other psychological techniques into office practice improved effectiveness in treating SD. Our 'Cornell Model' of sex therapy was based on the development of a treatment plan conceptualized from the rapid assessment of the immediate and remote causes of sexual dysfunction while maintaining rapport with the patient. 1, 2 This sex therapy approach integrated the work of Masters and Johnson as well as Helen Kaplan, using a four-phase model of human sexual response: desire, excitement, orgasm and resolution. 3, 5, 6 Sex therapy is the diagnosis and treatment of disruptions in any of these four-phases and/or the sexual pain disorders. These dysfunctions occur independent of each other, yet they frequently cluster. Personal distress and the impact of these dysfunctions on quality of life, is an important diagnostic consideration and has become a significant issue in sex research.
Sex therapy overview
Sex therapy is an 'efficacious' treatment for primary anorgasmia in women, some erectile failure in men, and is 'probably efficacious' for secondary anorgasmia y vaginismus in women and premature ejaculation in men. 7 Clinical experience supports efficacy in treating hypoactive sexual desire, sexual aversions, dyspareunia and delayed orgasm in men. Despite its potency, sex therapy receded as a treatment of choice during the 1990s as medical and surgical approaches performed by urologists established hegemony over the treatment of ED, in particular.
Sex therapy is an amalgam of individual and couple's therapy specifically focused upon improving sexual functioning. The sex therapist assigned structured erotic experiences carried out by the couple/individual in the privacy of their own homes. These exercises were designed to correct dysfunctional sexual behavior patterns as well as positively altering cognitions regarding sexual attitudes and self-image. This 'home play' modified the immediate causes of the sexual problem, allowing the individual to have mostly positive experiences creating a powerful momentum for a successful treatment outcome. The individually tailored exercises acted as therapeutic probes and were progressively adjusted until the individual or couple was gradually guided into fully functional sexual behavior.
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Do physicians ask?
The sexual dysfunctions each manifest a cluster of critical symptoms that point the way towards key questions which must be asked, and indicate which questions will not be as immediately important. The most important information can be obtained in a reasonable amount of time; physicians must discuss sex with their patients. Numerous CME programs have addressed the problem of encouraging physicians to both initiate and discuss sexual issues by emphasizing the importance of ED as a biological marker of disease among other reasons. Physicians were taught to 'bring up sex' directly or use segue techniques. [8] [9] [10] Many physicians learned about the statistically significant increase in the incidence of depression in men with SD. Treatment of SD may improve mild reactive depression, while depressive symptoms might alter response to therapy of SD. 11 A physician's history taking must parse out this 'chicken or egg problem:' Is SD causing depression or, is depression and its treatment (eg, SSRIs), causing the SD? The value of direct questioning about sex became especially clear here. If physicians did not ask, the patients may not tell. When asked direct questions, SSRI patients reported an increase, from 14 to 58%, in the incidence of SD versus spontaneous report. True incidence was probably underestimated as PDR data were based on patient spontaneous report. To manage adverse effects of medication, physicians learned to adjust dose or, combine with other drugs, to ameliorate the problem. 12 For instance, many might reduce the SSRI and supplement with buproprion or try sildenafil as a possible adjunct. While intrapenile injections or a 'combination approach' might be effective, sex therapy enhanced all these strategies.
Sex status: A 'sex status' or focused sex history is the sex therapists most important tool. Both sex therapists and physicians have used the 'sex status exam,' becoming 'sex detectives,' who juxtaposed detailed questions about the patient's current and past sexual history or status to unveil an understanding of the causes of dysfunction and noncompliance. 2 A good 'sex status' assessed all current sexual behavior and capacity. The interview was rich in detail, providing a virtual 'video image,' clarifying all aspects of the individual's behavior, feelings and cognitions regarding their sexuality. The most important diagnostic tool we have in understanding behavior is a clear and detailed description. A flood of useful material emerged when actively and directly evoked. 2 A comprehensive 'sex status' critically assists in understanding and identifying the 'immediate cause' F the actual behavior and/or cognition causing or contributing to the sexual disorder. Armed with this information, a diagnosis could be made and a treatment plan formulated. However, such detailed examination of current sexual behavior will also be of great utility to other health professionals. These sexual details provide important diagnostic leads. Significantly, the sexual information evoked in history taking will help anticipate non compliance with medical and surgical interventions. The 'Cornell Model' heuristically used immediate, intermediate and remote causal layering to help determine timing and depth level of intervention. Modifying immediate psychological factors results in less medication being needed for men and women, regardless of their specific SD. The similarity to the previous decades' integration of SSRIs with behavior therapy to treat depression should be apparent. Sex therapist's interventions are exercises and interpretations. In general, physicians will intervene with pharmacotherapy and brief 'sex coaching,' which addresses 'immediate causes' (insufficient stimulation) directly, intermediate issues (eg, partner) indirectly, and rarely focuses on deeper (eg, sex abuse) issues. Physicians manage current obstacles to sexual success, which typically are both organic and psychogenic in nature. In fact, when deeper psychological issues are the primary problem, it is usually time for referral. 13 A 'sex status' could become the physicians' most important tool in evaluating SD, as it is most consistent with the 'review of systems' common to all aspects of medicine. The 'sex status,' gives physicians critical information in less than 5 min. The 'sex status' allows the physician to initiate therapy with the least invasive method available; literally an 'oral therapy.' For this author, one question helps pin down many of the immediate and remote causes: 'tell me about your last sexual experience?' Common immediate causes of SD are quickly evoked by the patient's response. The most important cause of SD is lack of adequate friction and/or erotic fantasy, in other words, insufficient stimulation. Sex is fantasy and friction, mediated by frequency. To function sexually, people need sexy thoughts, not only adequate friction. While fatigue may be the most common cause of SD in our culture, negative thinking/antifantasy, whether a reflection of performance anxiety or partner anger, was also a significant contributor. Of course, the physician initiating the discussion of sex with the patient, in a mutually comfortable manner, transcended the importance of which question was asked.
The physician followed-up, with focused, openended questions to obtain a mental 'video picture.' Inquiries were made about desire, fantasy, frequency of sex, effects of drugs and alcohol. Did arousal vary during manual, oral and coital stimulation? What was the masturbation style, technique and frequency? Idiosyncratic masturbation was a frequent hidden cause of ED, as well as Delayed/Inhibited Ejaculation (IE).
14 The physician became implicitly aware of the patient's sexual script and expectations, leading to more precise and improved recommendations and management of patient expectations. For instance, a physician would improve outcome, by briefly clarifying whether a patient was better off practicing with masturbation, or reintroducing sex with a partner? A recently divorced man, who was using condoms for the first time in years, was probably better off masturbating with a condom rather than attempting sex with his partner, the first time he tried a new sex pharmaceutical.
Time crunch
'Time crunch' can be managed, even if the patient introduced the issue of SD as the physician reached for the door, or if earlier questions unleashed a delayed torrent of information and emotion. There was no need to despair, as there were four steps available to effectively manage 'time crunch.' First, the physician showed concern, and listened for 1 min to whatever the patient was saying. Second, the availability of help and hope was emphasized. Third, the physician sympathetically shared their time limitations, while empathizing with the importance of the topic and the necessity of adequate evaluation. Fourth, a new appointment (follow-up) to focus on the sex issue was scheduled. In this manner, the physician remained on schedule, while the patient was reassured, by both the physician's concern and the availability of forthcoming help. in 1998, primary care physicians (PCP) and urologists began incorporating sex therapy techniques with sexual pharmaceuticals to increase the effectiveness of their treatments for sexual dysfunction. If psychological issues did not spontaneously improve, the initial success of the sildenafil intervention was disrupted. Then, a combination approach was required and the patient often benefited from a sex therapy referral. Physicians were often right in their diagnosis, but patients did not follow directions. These were noncompliance issues. Sex therapists helped by reframing and readjusting unrealistic expectations. Many physicians have integrated these sex-coaching techniques into their office practices. Both the urological and psychological communities came to recognize and appreciate a new paradigm reflecting the interaction of both psychological and organic factors within a larger social context when treating SD. 6 A movement within the field of ED toward an integration of sex therapy and pharmacotherapy was articulated by both by urologists and by psychologists.
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Follow-up
Discussions of follow-up most vividly illustrated the importance of integrating sex therapy and pharmacotherapy. Barada and Hatzichristou led the way for urologists in placing tremendous emphasis on patient education (eg, food/alcohol effect), partner involvement and follow-up. [20] [21] [22] Patient education about the proper use of sildenafil was crucial to treatment effectiveness.
Most physicians initiated ED treatment using sildenafil, which is the only currently approved PDE 5 inhibitor. Nonetheless, treatment was also a 'therapeutic probe.' 3, 4 Initial failures examined at follow-up reveal critical information. The pharmaceutical acted as a therapeutic probe, illuminating the cause of failure or nonresponse. Retaking a quick 'sex status' provides a convenient model for managing follow-up. Physicians can increase their success by scheduling follow-up the first day they prescribe. As with any therapy, follow-up is essential to ensure an optimal treatment outcome. Components of the follow-up visit include monitoring side effects, assessing success and considering whether an alteration in dose or treatment is needed. Providing ongoing education to patients and their partners is useful, as well as involving them in treatment decisions whenever possible. A continuing dialogue with your patients is critical to facilitate success and prevent relapse. There are numerous psychological issues to consider which evoke noncompliance: fear of complications; reactions to changes associated with aging; reactions to chronic diseases or injury; changes associated with medications; alcohol, and smoking; changes associated with life stressors and other psychological issues: loss of partner, partner's attitude, etc. These are important issues in differentiating treatment non-responders from 'biochemical failures,' in order to enhance success rates. Early failures can be reframed into learning experiences and eventual success.
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Partner issues
Regaining potency, does not necessarily translate into the couple resuming sexual intercourse. Psychological issues may render the best treatments ineffective. PDE5 inhibitor discontinuation or failure rates of 20-40% are not due to adverse events. Resistance to lovemaking is often emotional and the most common 'mid-level' psychological causes of SD are relationship factors. 2, 4, 13, 16, 18, 23 There is a need for partner education, counseling and/or referral: when the partner's comfort with pharmacotherapy is too adversely effected by a concern for his safety; if compliance is adversely affected by a perception of the treatment being too 'artificial or mechanicalyis it me or the Viagra;' if her own capacity and readiness for sex is physiologically impaired for any of a multiplicity of reasons. 4, 9, 12, 13, 18 It is easy to extrapolate from the MMAS findings of increased ED frequency and severity with aging, that many aged men have older partners, who are also at risk for arousal phase disorders. 24 Finally, she may not be psychologically ready for sex. Since many men postpone treatment seeking for a year or more, the couple's sexual equilibrium may require a professional recalibrating the pace of intimacy resumption. 25 Both Hatzichristou and Barada have pointed out the amenability to brief counseling in the physician's office, of many immediate causes of ED. [20] [21] [22] Still the most common mid-level relationship causes may present considerable difficulty for the physician treating ED within the context of a typically brief office visit. How might this challenge be met? The complexity of this conundrum can be reduced or resolved. The physician's challenge is not necessarily requiring an office visit with the partner, as many CME programs have advocated. 8, 9, 12 Instead, the emphasis should be on evaluating the level of partner cooperation and support.
Urologist's and PCP's extreme success in treating ED has led many to disdain sex therapy's considerably more modest outcome research. Yet, there are many useful lessons from sex therapy to apply to urology and medical practice. One of the most important areas of interest to physicians, which can be learned from sex therapy, revolves around the partner issue. Since Masters and Johnson (1970) , sex therapists have recognized that sexual dysfunction is a 'couples problem,' not just the identified patient's problem. 6 However, almost equally long ago, myself and others noted that the key partner treatment issue was supportive cooperation, independent of actual attendance during the office visit. 5 Back in the 1970s and 1980s sex therapists argued about 'treatment format.' While Masters and Johnson used a daily 2-week residential conjoint model, most sex therapists today see outpatients individually and/or conjointly in weekly or biweekly sessions. Generally speaking, encourage partner attendance with married couples, allowing assessment and counseling for both. However, the issue is never forced. Treatment format is a psychotherapeutic issue and rapport is never sabotaged. While conjoint consultation is a good policy, it is not always the right choice! A man in a new dating relationship is probably better off seeing his therapist or physician alone, than stressing a new relationship by insisting on a conjoint visit.
While CME courses recommended that patientpartner-physician dialogue was best enhanced through patient/partner education during conjoint visits, there was anecdotal evidence that physicians were not regularly meeting with partners of ED patients. Do physicians meet with partners? In order to investigate this issue, the assistance of the leading American urologists in the field of ED were enlisted, by surveying the membership of the Sexual Medicine Society of North America. In advance of this presentation, approximately 200 members received an e-mail (via the 'EDNET' List Serve) requesting they complete a 15-item survey, prescreened by an expert panel of their members. In all, 44 urologists responded. A 20% response rate for an Internet survey is high, but this is not a representative sample. The data should be viewed as suggestive only. Complete methodology, results and discussion of this survey will be reported in a later article. However, some important and interesting highlights were noted.
The results pointed to a striking disparity between physician attitude and actual practice. An overwhelming 79% of the responding urologists considered partner cooperation with ED treatment 'important,' regardless of whether the partner actually attended sessions or not? A total of 21% of the responding urologists saw three of the 'partners', of their last five ED patients, during the initial visit. Tellingly, 39% of the responding urologists only saw one partner or less, of their last five ED patients. Nine percent never saw a partner at all! Nor was there any contact by phone, e-mail or other means between doctor and partners for 90% of the responding urologists. One might speculate that the urologists were treating only unpartnered patients. Yet, in reality, the vast majority of patients were married or coupled.
Clearly, office behavior and attitude did not align, as many urologists were seeing few couples conjointly. Was this bad practice and should they feel guilty? No! There were a number of good reasons for not having a conjoint visit, as long as the importance of partner issues in treatment success was understood. Indeed many urologists reflected thoughtfully, on the burden of the treater to not invade the privacy, beyond what was freely accepted by the patient. Urologists noted that the men saw the ED as their problem, and were not interested in involving their partner. These urologists gently encouraged partner attendance, but appropriately did not require it. So why are pharmaceutical ED treatments so effective? Does these data suggest that partner issues do not impact outcome? No, but it does support the thesis that 'partner cooperation' is even more important than 'partner attendance.' Why are physicians successful even when not seeing partners? Sex pharmaceuticals plus sex counseling and education work for many people, if the partner was cooperative in the first place. Fortunately, many partners of both men and women are cooperative, which partially accounts for the high success rates of medical and surgical interventions.
Indeed, most of the cooperation goes unexplored. The cooperation is assumed, based on post hoc knowledge of success. Importantly, many women were cooperating with their partners, or facilitating sexual activity, independent of their knowledge of the use of a sexual aid or pharmaceutical. In other words, ' we did what we used to do and it worked!' ED patients, characterized partners, whose attendance might not be required, as supportive, encouraging and cooperative, These characteristics were sometimes implicit rather than manifest. They were willing and capable of being sexual. They had a willingness to allow sex to improve progressively, rather than requiring all improvement to be immediate and perfect. They were supportive of reasonable professional recommendations. They explicitly understand that sexual pharmaceuticals are useful aids to restoring their sex life, not chemical competition for their partner's affection. They were less concerned that a sexual pharmaceutical would result in a partner's sexual 'acting out. ' Clinical experience showed us many of these patients had good outcomes even if the partners never attended an office visit. However, good becomes better by evaluating, understanding and treating key partner issues. The physician must differentiate the complaining, sabotaging partner, from the encouraging, supportive one, as both may pressure the ED patient to seek help. Obviously, the most pleasant, supportive, cooperative partners would rarely be discouraged from attending office visits with the 'ED patient.' Ironically, these same patients would probably have successful outcomes even if their partners never attended an office visit. Their partners were less likely to be resistant to the restoration of sexual health, and indeed many of them were the treatment seeking 'drivers' in the first place. 25 The existence of large numbers of cooperative, supportive women who themselves have partners with mild to severe ED account for much of the success of many ED patients who see their physicians alone, for evaluation and subsequent pharmacotherapy. Many of these partners were never seen by the treating physician, nor was their attendance necessary for success.
The patient-partner-physician dialogue is best enhanced through patient/partner education. Partner attendance during the office visit would allow for such education. Yet, physicians do not regularly meet with partners of ED patients. Earlier we discussed why such meetings might not be necessary at all. Additionally, although working with couples was often recommended: sometimes there was no partner; sometimes the current sexual partner was not the spouse, raising legal, social and moral sequella. 9, 12 The reality and cost/benefit of partner participation is a legitimate issue for both the couple and the physician, and not always a manifestation of resistance. Finally, the patient's desire for his partner's attendance may be mitigated by a variety of intrapsychic and interpersonal factors, which, at least initially, must be respected and heeded.
There are other solutions. When evaluation or follow-up reveals significant relationship issues, counseling the men alone may help, but interacting with the partner will often increase success rates. If the partner refuses to attend, or the patient is unwilling or reluctant to encourage them; seek contact with the partner by telephone. Ask to be called, or for permission to call the partner. Most partners find it difficult to resist speaking 'just once,' about 'potential goals' or 'what's wrong with their spouse.' The contact provides opportunity for empathy and potential engagement in the treatment process, which may minimize resistance and improve outcome further. This effective approach could be modified depending on the physician's interest and time constraints.
Physicians should counsel partners when necessary and possible. They need to be a resource; treating with medication, counseling and educational materials. Education needs to be a greater part of ED practice, whether provided by the doctor and/ or physician extenders. One urologist reported using his own 10-min ED education video, sent home with each patient. Given his unusual motivation and effort, not surprisingly he scored the highest in partner attendance of any urologist surveyed. Many urologists and PCPs are neither motivated, nor have the time to develop and implement such an approach. However, if treatment success rates are to be boosted even higher, then partner issues must be addressed in some other manner.
Patient and partner education: consumer education materials
Recently, more professional society meetings have recognized the importance of 'partner participation' in their educational programs. 4, [24] [25] [26] [27] Yet, many urologists were not necessarily motivated or successful in obtaining partner attendance. Furthermore, actual partner attendance during the office visits was not always a necessary aspect of successful treatment of the man with ED. We have examined these issues with an eye towards a different hypothesis. Specifically, that supportive partner cooperation is the key therapeutic contributor to success and that actual participation, although usually reflecting cooperation, is not always necessary and may even be contraindicated. All these factors point to the importance of industry developing partner education, as well as patient educational materials for physician use.
The variety of different issues surrounding office attendance of partners of ED patients highlights the importance of partner education materials being available for the ED patient. Whenever possible we want to empower these 'impotent' men to educate their partners, by providing them with knowledge and tools. It is, of course, critical that the 'partner' never 'hear' a message of 'blame' for the problem. These are suggestions for enhancement, not faultfinding. The education materials should be available in a variety of different media, to allow for different learning styles. This information needs to be disseminated to the public at large, and not only targeted for the physician's office. Advertising and public relations could be directed toward educating the partner on how to improve their intimate life. This could be as simple as normalizing a woman's age-related changes, with suggestions for using supplemental lubrication. Other material would tastefully explain a man's need to feel sexual and be touched sexually for a sexual pharmaceutical to be effective.
This patient/partner-based approach would result in greater success rates, with minimal extra physician time required. Early sex therapy discussed the benefit of education, permission giving and brief counseling. During the 1970s and 1980s this was frequently all that was necessary, to successfully alter the sexual equilibrium necessary to restore sexual health for some dysfunctional individuals. Over time, this information became part of the cultural backdrop and therapists complained, 'cases are more difficult and complex.' Similar to sex therapy in the 1970s, sexual pharmacology is in its infancy. Success rates can be enhanced through patient-partner-physician education, which will reduce the frequency of noncompliance, partner resistance and minimize symptomatic relapse. Organic and psychological factors causing sexual dysfunction, and noncompliance with treatment, are on a multilayered continuum. While some partners will require direct professional intervention, many others could benefit from obtaining critical information from the ED patient and/or multiple media formats both private and public.
An important caveat to this discussion involves situations where partner attendance during the office visit is probable. Partners of patients suffering life-threatening situations (eg, cancer, heart attack, stroke) are likely to meet with the treating physician. While the initial concern is potential death, quality of life issues will certainly emerge as a focus sometime during the treatment or recovery process. The treating physician has ample opportunity to provide important sex coaching and/or an appropriate referral. The existence of better patientpartner educational tools would, of course, only enhance these efforts.
Referral
If the partner's support for successful resolution of the ED is not present, then active steps must be taken to evoke it. Frequently, brief counseling by the physician of the ED patient is sufficient. Yet, a conjoint referral for adjunctive treatment to a sex therapist and/or gynecologic or endocrine referral for the partner may also be required. Of course the more problematic the relationship, the more profound the marital strife, the less likely that patientpartner sex education will be able to successfully augment treatment in and of itself. Inevitably, a referral would be required, albeit not necessarily accepted successfully.
Identifying psychological factors does not necessarily mean the physician must treat them. If not inclined to counsel, or, if uncomfortable, the physician may consider referring or working conjointly with a sex therapist. The physician should be encouraged to practice to his or her own comfort level. PDE5 inhibitors are extremely effective drugs, but they do have limitations. 23 Some of these limitations created a 'born-again' role for sex therapists, although a more complex and sophisticated one. Physicians who prescribed sildenafil and wanted adjunctive assistance, referred to sex therapists because of their own psychological sophistication or because of noncompliance on the part of their patient. 13 Whether the referral is physician or patient initiated, sex therapists are ready to effectively assist in educating the patient about maximizing his or her response to the sexual situation. They are able to help physicians remotivate people who have failed initial medical treatments, as well as helping patients to adjust to second and third line interventions. 19 They help make patients receptive to trying again. Sex therapists are also equipped to help resolve the intrapsychic and interpersonal blocks to restoring sexual health. Finally, sex therapists are skilled in using cognitive-behavioral techniques for relapse prevention. 28 
Conclusion
It is certainly important to for physicians to discuss sexual health with their patients. Techniques and options are available for integrating sex therapy and pharmacotherapy into routine office practice of both urologists and PCPs. Incorporating sex coaching will enhance physician's relationships with their patients and increase their success in improving their patient's sexual health. While meeting with partners of patients may be desirable, there are alternative options for enhancing a man's sexual functioning. In particular, more patient and partner educational materials are needed for the physicians 'tool box' to assist him or her in overcoming a patient/partner's emotional barriers to sexual success in a time efficient manner. New questions will arise about when, where, and how, to use these materials. There will be new medical and surgical treatments in the future. Sex therapists have a role in this dialogue and sex therapy complements all of these approaches. This author is optimistic, for our future, using an integrated, sexual pharmaceutical, and sex therapy approach to facilitate treatment and minimize relapse.
